Sin3B loss reshapes the tumor microenvironment, leading to increased infiltration as well as cytotoxicity of CD8+ T cells, to impede PDAC progression and enhance sensitivity to anti‐PD1 treatment. Here, SIN3B is linked to neoplasm.